This bill, titled the Permanent CBDC Ban Act, aims to permanently prohibit the Federal Reserve from issuing a central bank digital currency. It achieves this by amending the Federal Reserve Act to remove the specific legal authority that allows the Reserve to create such a digital currency. The legislation directly affects the Federal Reserve by stripping away its power to launch a digital version of the dollar. By deleting the relevant subsection of the law, the bill ensures that the Reserve cannot issue a CBDC in the future.
The Great American Healthcare Act introduces several changes to the U.S. healthcare system, primarily focusing on expanding Health Savings Accounts (HSAs) and increasing price transparency for medical services. Under the HSA provisions, individuals can contribute more money to these accounts, use funds for healthy food and fitness expenses, and roll over unused balances to family members or specific political accounts. The bill also allows employers to satisfy certain coverage mandates by contributing directly to employees' HSAs. To make healthcare costs clearer, the legislation requires hospitals, laboratories, and imaging centers to publicly post their standard charges and negotiated rates in a uniform format. Additionally, the bill mandates that health plans provide detailed itemized bills and explanations of benefits to patients within 45 days of a claim request. Finally, the act expands the ability of pharmacists and nurses to dispense certain low-risk prescription drugs without a doctor's direct supervision and repeals a specific rule regarding Federal Reserve earnings on balances.
The Read for Reentry Act of 2026 directs the Comptroller General of the United States to conduct a study on library services within state and federal prisons. This report will examine who currently has access to these services, how they are funded, and the demographic characteristics of incarcerated individuals who use them. The study will also analyze specific outcomes related to recidivism, parole compliance, workforce placement, and disciplinary infractions for those released from facilities offering library programs. Ultimately, the bill aims to gather data to inform Congress about the current state and impact of prison libraries.
This bill requires the Comptroller General of the United States to conduct periodic assessments of federally funded programs managed by state and local governments to identify risks of waste, fraud, and abuse. The report will analyze specific administrative practices that create vulnerabilities and evaluate which current strategies effectively reduce these risks. It also aims to recommend improvements for federal tools and enrollment processes to better protect public funds. Ultimately, the legislation seeks to enhance oversight by providing Congress with a clear picture of where federal money administered by states is most susceptible to misuse.
The BOASBERG Act mandates that federal district and appellate courts use random methods to assign civil cases and judges to panels, ensuring that no party, attorney, or judge can influence which judge hears a specific case. While this randomization applies broadly, the bill allows for exceptions in limited situations such as when a judge must recuse themselves, when cases are consolidated for efficiency, or when a chief judge certifies a need for reassignment based on docket management rather than the parties involved. The legislation also requires courts to publish transparency reports explaining any deviations from random assignment and imposes penalties, including sanctions or disciplinary action, on individuals who attempt to manipulate the assignment system.
S 2658, the Medication Affordability and Patent Integrity Act, requires drug manufacturers to certify that patent information submitted to the FDA for new drug approvals matches what they provided to the U.S. Patent and Trademark Office (USPTO). It mandates that sponsors submit patent-related data to the USPTO and certify its accuracy, ensuring consistency between FDA and patent filings for drugs and biologics. The bill creates a new legal defense for generic drug makers in patent lawsuits if a brand-name company failed to disclose required patent information. This applies to new drug applications filed after the law's enactment, directly affecting pharmaceutical companies seeking FDA approval for new medications.
The Patients Deserve Price Tags Act requires hospitals, clinical diagnostic laboratories, imaging services providers, and ambulatory surgical centers to publicly disclose detailed pricing information for healthcare services in machine-readable formats. This includes standard charges, discounted cash prices, payer-specific negotiated rates, and other relevant pricing data that consumers can easily access and compare. The law applies to all facilities that provide services to Medicare beneficiaries, with implementation dates starting in 2026 for hospitals and 2027 for other providers. Non-compliant facilities face daily civil monetary penalties ranging from $300 to $10,000 per day, depending on facility size and duration of non-compliance.
This bill simplifies the approval process for biosimilar drugs - medicines that are highly similar to, but not identical to, existing biologic drugs. It amends the Public Health Service Act to clarify when biosimilars are deemed "interchangeable" with the original drug (allowing pharmacists to substitute them without a doctor's specific order), adjusts exclusivity periods for existing biosimilars, and sets a 60-day transition period after enactment. The bill also requires the FDA to update its guidance documents within 18 months to reflect these changes. This directly affects pharmaceutical companies developing biosimilars, the FDA in its review process, and ultimately patients seeking more affordable treatment options.
This resolution expresses the sense of the House of Representatives that Charleston, South Carolina, should proceed with hosting the 2027 annual meeting of the Organization for Security and Cooperation in Europe Parliamentary Assembly. The bill cites Charleston's existing facilities as suitable for the event and notes that hosting the convention in South Carolina honors the legacy of late Senator Lindsey Olin Graham. It also highlights that the United States has not hosted this specific assembly since 2005. The measure does not change any laws or allocate funding but serves as a formal statement of support for the planned event.
The Temporary Protected Status Review Act restores the ability of courts to review decisions by the Department of Homeland Security to end Temporary Protected Status (TPS) designations for foreign nationals. Under this bill, the government must publish detailed written findings explaining why a country no longer qualifies for TPS protection, and these decisions would be subject to a legal challenge in federal court. If a TPS designation is terminated, the affected individuals would remain in the United States with their current status and work authorization intact while the legal challenge is pending. Additionally, the legislation requires the government to follow specific administrative procedures, such as considering all available evidence and avoiding bias, before making any termination decisions.
This bill establishes federal protections and funding to expand access to in vitro fertilization and intrauterine insemination for individuals, military service members, and veterans. It requires most private health plans, Medicaid programs, and Medicare to cover these fertility treatments without imposing higher cost-sharing than other medical services. Additionally, the legislation mandates that the Department of Defense and the Department of Veterans Affairs provide specific fertility preservation and treatment benefits to uniformed service members and eligible veterans. The bill also includes preemption clauses that override state laws restricting these procedures and prohibits discrimination based on marital status, sex, or sexual orientation in the provision of care.
The Transportation for Reentry Act requires transit agencies receiving federal funding to offer free public transportation to individuals released from prison after serving at least one year. Under this bill, these agencies must provide the service for one year starting from the person's release date and cover costs related to program setup, staff training, and outreach. To receive federal grants, transit recipients must establish enrollment systems, track usage data, and ensure compliance with the program's duration requirements. The legislation authorizes $40 million annually from 2027 to 2031 to support these efforts and mandates a final report on the program's impact five years after enactment.
